GANDOLFO, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 3.027
NA - Nord America 2.906
AS - Asia 1.584
SA - Sud America 299
AF - Africa 114
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.937
Nazione #
US - Stati Uniti d'America 2.855
RU - Federazione Russa 735
IT - Italia 567
SG - Singapore 514
IE - Irlanda 495
GB - Regno Unito 399
CN - Cina 354
VN - Vietnam 292
BR - Brasile 237
SE - Svezia 182
DE - Germania 161
FR - Francia 146
HK - Hong Kong 139
FI - Finlandia 110
IN - India 64
UA - Ucraina 64
ZA - Sudafrica 58
KR - Corea 52
PL - Polonia 33
BD - Bangladesh 31
ES - Italia 29
NL - Olanda 23
CA - Canada 21
MX - Messico 20
TR - Turchia 20
BE - Belgio 19
PK - Pakistan 16
AR - Argentina 15
IQ - Iraq 14
JP - Giappone 14
CO - Colombia 13
NG - Nigeria 13
AT - Austria 12
CI - Costa d'Avorio 11
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
IM - Isola di Man 9
CZ - Repubblica Ceca 8
ID - Indonesia 8
EC - Ecuador 7
MA - Marocco 7
CL - Cile 6
EG - Egitto 6
PE - Perù 6
VE - Venezuela 6
IL - Israele 5
KE - Kenya 5
TN - Tunisia 5
UZ - Uzbekistan 5
BG - Bulgaria 4
DZ - Algeria 4
IR - Iran 4
LT - Lituania 4
MT - Malta 4
PT - Portogallo 4
PY - Paraguay 4
UY - Uruguay 4
CH - Svizzera 3
EU - Europa 3
JO - Giordania 3
KZ - Kazakistan 3
MY - Malesia 3
TH - Thailandia 3
AL - Albania 2
AM - Armenia 2
AU - Australia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
RO - Romania 2
AO - Angola 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PW - Palau 1
QA - Qatar 1
Totale 7.933
Città #
Dublin 480
Singapore 324
Dallas 322
Southend 308
Ashburn 246
Chandler 218
Fairfield 204
Moscow 204
Santa Clara 178
Siena 164
San Jose 137
Hong Kong 128
Beijing 104
Wilmington 91
Ho Chi Minh City 81
Houston 76
Ann Arbor 75
New York 74
Woodbridge 74
Council Bluffs 73
Cambridge 71
Milan 69
Seattle 69
Princeton 68
Helsinki 67
Los Angeles 66
Hanoi 62
The Dalles 59
Munich 58
Jacksonville 52
Seoul 50
Lauterbourg 48
Hefei 46
Johannesburg 46
Rome 43
Florence 33
Warsaw 31
Fremont 27
Dong Ket 25
São Paulo 25
Menlo Park 24
Da Nang 20
Buffalo 19
Frankfurt am Main 19
Shanghai 19
San Mateo 17
Turku 17
Brussels 16
Atlanta 14
Boardman 14
Chennai 14
Málaga 14
San Diego 14
Haiphong 13
London 13
Nanjing 13
Redondo Beach 13
Tokyo 13
Abuja 12
Chicago 12
Lappeenranta 12
Montreal 12
Nuremberg 12
Abidjan 11
Lancaster 11
Orem 11
Düsseldorf 10
Portsmouth 10
Columbus 9
Dearborn 9
Denver 9
Falls Church 9
Boston 8
Douglas 8
Izmir 8
Phoenix 8
Poplar 8
Rio de Janeiro 8
Bengaluru 7
Biên Hòa 7
Karlsruhe 7
Messina 7
Shenyang 7
Baghdad 6
Dubai 6
Espoo 6
Hải Dương 6
Norwalk 6
Stockholm 6
Vienna 6
Ankara 5
Brooklyn 5
Dhaka 5
Falkenstein 5
Guangzhou 5
Istanbul 5
Jeddah 5
Madrid 5
Manchester 5
Mexico City 5
Totale 5.186
Nome #
A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease 376
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 333
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 317
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 285
Antibody response to SARS-CoV-2 in infected patients with different clinical outcome 277
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 265
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 264
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 254
Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020 247
Host-pathogen interaction: study of Toscana virus 246
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine 223
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 214
Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy 213
Identification of a neutralizing epitope on tosv gn glycoprotein 212
Detection of asymptomatic SARS-CoV-2 infections among healthcare workers: Results from a large-scale screening program based on rapid serological testing 210
Human Polymorphonuclear Cells Support Zika Virus to Cross Endothelial Monolayer and Access Bloodstream 199
Infection prevention in endoscopy practice; comparative evaluation of reusable vs single use endoscopic valves 197
Omicron infection evokes cross-protection against SARS-CoV-2 variants in vaccinees 186
Efficient inactivation of sars-cov-2 and other rna or dna viruses with blue led light 182
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID 180
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 176
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection 176
Comparative performance of a new sars-cov-2 rapid detection system 174
Neutralizing antibody response of vaccinees to SARS-CoV-2 variants 172
Ubiquitin and not only unfolded domains drives toscana virus non-structural NSs protein degradation 170
Infectious Toscana virus in seminal fluid of young man returning from Elba Island, Italy 170
Toscana virus non-structural protein NSs acts as E3 ubiquitin ligase promoting RIG-I degradation 168
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines 166
Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs era 164
How long can SARS-CoV-2 persist in human corpses? 163
Epidemiology of Toscana virus in South Tuscany over the years 2011-2019 158
Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion 153
Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine 153
Toscana virus infects dendritic and endothelial cells opening the way for the central nervous system 144
Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience 141
Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified? 140
Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix 116
Detection of SARS-CoV-2 N protein allelic variants by rapid high-throughput CLEIA antigen assay 114
null 103
Truncation of the C-terminal region of Toscana Virus NSs protein is critical for interferon-β antagonism and protein stability 103
SARS-CoV-2 n protein targets TRIM25-mediated RIG-I activation to suppress innate immunity 97
Validation of Two Commercial Multiplex Real-Time PCR Assays for Detection of SARS-CoV-2 in Stool Donors for Fecal Microbiota Transplantation 92
Totale 8.093
Categoria #
all - tutte 27.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.022


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021207 0 0 0 0 0 0 0 0 0 83 39 85
2021/2022529 34 33 24 39 23 27 21 16 99 45 57 111
2022/2023758 42 92 98 80 75 154 18 74 59 25 25 16
2023/2024862 24 51 70 47 35 212 307 24 7 14 16 55
2024/20251.440 57 61 158 94 163 98 94 94 160 80 157 224
2025/20263.086 228 383 282 460 733 139 450 86 129 196 0 0
Totale 8.093